Drug Shortage Report for TEVA-ATOMOXETINE
Report ID | 109632 |
Drug Identification Number | 02314576 |
Brand name | TEVA-ATOMOXETINE |
Common or Proper name | ATOMOXETINE 25MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ATOMOXETINE |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | PP 30 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-25 |
Estimated end date | |
Actual end date | 2021-04-09 |
Shortage status | Resolved |
Updated date | 2021-04-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-26 | English | Compare |
v2 | 2020-03-26 | French | Compare |
v3 | 2020-07-16 | English | Compare |
v4 | 2020-07-16 | French | Compare |
v5 | 2020-08-20 | English | Compare |
v6 | 2020-08-20 | French | Compare |
v7 | 2021-04-15 | English | Compare |
v8 | 2021-04-15 | French | Compare |
Showing 1 to 8 of 8